Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4445907 | 0.89 | PAX8 (0.35) | GFERPOLBMEN1KMT2ATNKS | |
| SCHEMBL3593660 | 0.89 | PAX8 (0.35) | GFERPOLBMEN1KMT2ATNKS | |
| SCHEMBL3593757 | 0.77 | KDM4E (0.39) | POLBALDH1A1LMNA | |
| SCHEMBL3585606 | 0.73 | HTR1A (0.38) | GFERPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL14161702 | 0.72 | GFER (0.34) | GFERMEN1KMT2A | |
| SCHEMBL3587166 | 0.71 | FADS1 (0.38) | GFER | |
| SCHEMBL3599584 | 0.71 | MAPK14 (0.37) | GFERMEN1KMT2ALMNA | |
| SCHEMBL3595647 | 0.70 | POLB (0.37) | POLBKMT2A | |
| SCHEMBL3586963 | 0.70 | ALOX15 (0.41) | GFERPOLBMEN1KMT2A | |
| SCHEMBL15181621 | 0.70 | RXFP1 (0.39) | GFERPOLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234365-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY | IRM LLC (BM) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234365-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY | CNR1, CNR2, FAAH | GFER 2722/4885POLB 4041/4885MEN1 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.